Skip to content
  • Sunday, 26 July 2026
  • 6:39 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
Clinical Diagnostics & Pathology

With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.

Reynand Amr Wu Apr 2, 2026 0

The Centers for Medicare and Medicaid Services (CMS) has initiated a critical dialogue with the clinical laboratory community, seeking direct…

Read More
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Diverse Medical Topics from Screwworm to Scientific Advocacy

Lina Irawan Apr 2, 2026 0

In a comprehensive clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin, alongside host Vincent…

Read More
Clinical Diagnostics & Pathology

Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.

Reynand Amr Wu Apr 1, 2026 0

Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu Apr 1, 2026 0

The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…

Read More
Clinical Diagnostics & Pathology

Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.

Reynand Amr Wu Mar 30, 2026 0

A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…

Read More
Clinical Diagnostics & Pathology

Breath-based VOC analysis could give clinical labs a faster, noninvasive way to assess gut microbiome health and detect disease earlier.

Reynand Amr Wu Mar 30, 2026 0

The landscape of clinical diagnostics is on the cusp of a significant transformation, with new research pointing towards a rapid,…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global Commercialization

Reynand Amr Wu Mar 29, 2026 0

Utrecht, Netherlands – Vitestro, a pioneering medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Mar 29, 2026 0

The United States’ withdrawal from the World Health Organization (WHO) and proposed changes to vaccine mandates have ignited significant debate…

Read More
Clinical Diagnostics & Pathology

How Clinical Laboratories Can Prepare for Crisis Events Before They Happen

Reynand Amr Wu Mar 28, 2026 0

Clinical laboratories, the silent sentinels of public health, operate at the nexus of patient care and scientific precision. Yet, this…

Read More
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Mar 27, 2026 0

This groundbreaking research from the Johns Hopkins Kimmel Cancer Center heralds a new era in early cancer detection, introducing a…

Read More

Posts pagination

1 … 20 21 22 … 25
QIAGEN Digital Insights Partners with NVIDIA to Revolutionize AI-Driven Drug DiscoveryRice University Researchers Develop First Comprehensive Label-Free Molecular Atlas of the Alzheimer’s BrainThe Joint Clinical Assessment: Navigating Procedural and Methodological Hurdles in EU Drug EvaluationTWiV 1291: A Foot in the Door for Cytomegalovirus
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ